Related Experiment Videos

Systemic hypoglycemia following central injection of endotoxin in mice

Brain Research
|July 29, 1985
PubMed

Insights

Endotoxin and lipid A cause severe hypoglycemia via the central nervous system (CNS). Polymyxin B or endotoxin detoxification prevents this effect, indicating a direct CNS role in endotoxin-induced hypoglycemia.

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • Endotoxins are potent immune activators.
  • Endotoxin administration can lead to metabolic disturbances, including hypoglycemia.
  • The precise mechanisms underlying endotoxin-induced hypoglycemia are not fully understood.

Purpose of the Study:

  • To investigate the role of the central nervous system (CNS) in endotoxin-induced hypoglycemia.
  • To determine if the biologically active component of endotoxin, lipid A, directly affects CNS function.
  • To explore potential interventions for mitigating endotoxin-induced hypoglycemia.

Main Methods:

  • Microinjection of endotoxin and lipid A into the cerebrospinal fluid of mice.
  • Administration of polymyxin B (PMB) or detoxified endotoxin.
  • Assessment of blood glucose levels following central and systemic endotoxin/lipid A administration.

Main Results:

  • Intracerebroventricular endotoxin induced significant hypoglycemia in mice.
  • Lipid A reproduced the hypoglycemic effect of endotoxin.
  • Polymyxin B administration or endotoxin detoxification prevented hypoglycemia.
  • Central PMB treatment attenuated hypoglycemia from both central and systemic endotoxin/lipid A.

Conclusions:

  • The central nervous system plays a direct role in the mechanism of endotoxin-induced hypoglycemia.
  • Lipid A is the primary mediator of this CNS effect.
  • Polymyxin B and endotoxin detoxification are effective in preventing endotoxin-induced central hypoglycemia.

Related Concept Videos